Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Trader Note — 15007 total
Quantinuum enters the back half of August with a striking disconnect: insiders spent $44.8 million buying stock in June at $60, yet the share price has since slipped to $56.06 — meaning every one of those buyers is…
DPC Holdings PLC is a newly listed NYSE stock with a striking setup: the stock has climbed 10% in a month, the Street is freshly initiated with mostly bullish targets, and a cluster of C-suite insiders spent over $75…
NVRI heads into Thursday's earnings print with its worst weekly performance in months and a cluster of recent insider buying sitting firmly underwater. The stock closed Tuesday at $20.14, down 7.9% on the day and 15.6%…
EROC just reported its first earnings as a public company, and the data heading into that print — and now out the other side — captures a stock where the Street is overwhelmingly bullish, insiders sold heavily at IPO,…
Octave Intelligence enters the second half of August with an unusual alignment: insiders poured more than $4 million into the stock in June, and short sellers have been quietly covering ever since. The insider buying…
Applied Aerospace & Defense enters its first weeks of NYSE life with a quietly interesting tension: short interest jumped sharply on a single day, yet the lending market remains extremely loose and borrowing costs have…
FRVO enters its August 12 earnings release with an unusual split in sentiment: the Street has grown more constructive on the geothermal developer over the past month, yet options positioning has shifted meaningfully…
Lincoln International enters this week as one of the more striking post-earnings stories in the financial services space — a stock that jumped 19% in a single session and has since drawn a clutch of fresh analyst…
EROK has posted its strongest weekly gain since listing, jumping 18% to $25.85 after its debut earnings print came in strong enough to prompt an immediate analyst response — and the setup heading into the next quarter…
Alamar Biosciences enters the week after its sharpest rally of the year, with a 35% gain forcing analysts to scramble and short sellers to reassess a position that looked comfortable just days ago. The catalyst is…
COAG enters its August 20 earnings date having more than doubled the pace of its short position in a month — yet the stock keeps climbing anyway. The most striking dynamic on Hemab Therapeutics this week is a…
AVLN enters the week with a sharp disconnect between rising conviction from buyers and a short base that is quietly unwinding — while the next earnings catalyst is just three weeks away. The stock gained 15.4% over the…
APC has dropped 11% this week following its August 6 earnings release, and the post-print reaction has sharpened the tension between a Street that remains constructive and a market that is voting with its feet. The…
PURR enters the back half of August with a contradictory setup: shorts are retreating on the week, yet the one-month picture tells a story of sustained bearish accumulation that is hard to ignore. The most striking…
SharonAI Holdings heads into its August 14 earnings print with the lending market nearly locked shut and short sellers adding positions at the fastest monthly pace since the stock began trading — a setup that puts…
MDLN enters the post-earnings period carrying a fresh 17% weekly loss and a wave of analyst price-target cuts — a rare moment of unified Street pessimism that still hasn't shaken anyone's positive ratings. The week's…
Cardinal Infrastructure Group entered the week trading near $65 and exited it at $38.27 — a 40% collapse in five sessions that transformed one of 2026's standout construction winners into a post-earnings wreck. The…
Wolfspeed heads into its August 19 earnings report with the lending market completely exhausted and short interest running at an extreme — a setup that makes the upcoming print one of the more electrically charged on…
WBI enters the post-earnings period with a split signal: short sellers have started rebuilding positions following a weak reaction to August results, even as the Street's two bellwether analysts have just lifted their…
LB Pharmaceuticals enters a pivotal moment: short sellers are rebuilding positions at the fastest pace in months, yet options traders have abruptly abandoned their defensive stance — a sharp divergence that frames the…
